Anti-dsDNA IgG, IgA, and anti-C1q can be used to evaluate disease activity, and anti-dsDNA IgM as well as anti-C1q can help to better distinguish between LN and non-LN patients. This evidence concerns the gene CD79A and lobular neoplasia.